Iron supplementation in prematurity: how much is too much?
Kling
Pamela J
PJ
D000284:Administration, Oral; D000751:Anemia, Neonatal / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D008297:Male; D011994:Recombinant Proteins; D018570:Risk Assessment
D005296:Ferrous Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin